학술논문
Impact of viral aetiology in the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC)
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15698041